Drug intelligence / Profile preview

iron(III) hydroxide polymaltose complex

Development stage
Unknown
Lead developer
Shayana Farm
Modality
Small Molecules
Administration
Oral
01

Overview

Feromaks is an oral iron supplement developed and marketed by Shayana Farm, primarily available in a syrup formulation. The active ingredient is iron(III) hydroxide polymaltose complex (IPC), a non-ionic iron preparation where the polynuclear iron(III) hydroxide core is surrounded by non-covalently bound polymaltose molecules. This complex is designed to mimic the physiological storage form of iron (ferritin), allowing for controlled iron release and absorption via active transport mechanisms in the small intestine. This pharmacokinetic profile significantly reduces the risk of gastrointestinal irritation and oxidative damage often associated with traditional ferrous salts. Feromaks is indicated for the treatment of latent iron deficiency and iron deficiency anemia, as well as for the prevention of iron deficiency during pregnancy and lactation.

Brand names
Feromaks
Other names
Feromaks syrup
02

Targets

SLC11A2 (DMT1)SLC40A1 (Ferroportin)

Beyond the preview

Go deeper on iron(III) hydroxide polymaltose complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iron(III) hydroxide polymaltose complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call